GLOW blend
GLOW (GHK-Cu + BPC-157 + TB-500)
Also known as: GLOW stack, GLOW peptide
A three-peptide vendor blend (GHK-Cu, BPC-157, TB-500, typically 70 mg) marketed for skin and recovery; unstudied as a combination and mostly copper peptide by mass.
Overview
GLOW is KLOW without the KPV, positioned for aesthetic goals. The GHK-Cu component has real topical skin data; BPC-157 and TB-500 have animal healing data. There is no trial of the three injected together, no stability study of the mixture, and no basis for a combined dose. The same copper-load and angiogenesis caveats as KLOW apply, including avoidance with active cancer because two components promote blood-vessel growth in animal models.
Mechanism of action
Assumed additive: GHK-Cu collagen and remodeling signals plus BPC-157/TB-500 repair pathways, from separate animal and in-vitro studies.
Key studies & citations
- Review2024
GHK-Cu in skin: topical clinical studies (review)
Topical GHK-Cu improved skin appearance in small studies; injected use unstudied.
PubMed - Review2025
The Wolverine stack: what the research says
BPC-157 and TB-500 research never reached human clinical trials.
Healthline
Frequently asked questions
Does the GLOW stack work for skin?
There is no study of the blend. Topical GHK-Cu has small clinical studies for skin appearance; injecting it with two other peptides has none.